Empagliflozin in type 1 diabetes

Empagliflozin in type 1 diabetes

Chantal Mathieu, Laura Van Den Mooter, Bert EeckhoutEndocrinology, UZ Gasthuisberg, Leuven 3000, BelgiumCorrespondence: Chantal MathieuEndocrinology, UZ Gasthuisberg, Herestraat 49, Leuven 3000, BelgiumEmail chantal.mathieu@uzleuven.beAbstract: There is a clear unmet need in people living with type...

Full description

Bibliographic Details
Main Authors: Mathieu C, Van Den Mooter L, Eeckhout B
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
type 1 diabetes
SGLT2 inhibitor
empagliflozin
EASE trials
Online Access:https://www.dovepress.com/empagliflozin-in-type-1-diabetes-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/empagliflozin-in-type-1-diabetes-peer-reviewed-article-DMSO

Similar Items